Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Remicade
Remicade
FDA Accepts First-Ever Biosimilar Application for Monoclonal Antibody
RAPS.org
Mon, 08/11/14 - 11:13 am
Remsima
Remicade
monoclonal antibodies
FDA
Celltrion
biosimilars
Drugs That Will Help Johnson & Johnson Grow By 5% In 2014
Forbes
Wed, 04/30/14 - 10:28 am
JNJ
Remicade
Olysio
Velcade
Zytiga
A Second Lawsuit Tests the BPCIA Biosimilars “Patent Dance” Waters
FDA Law Blog
Wed, 04/2/14 - 07:45 am
patents
biosimilars
Celltrion
Janssen Biotech
Remicade
The 10 best-selling drugs of 2013
Fierce Pharma
Tue, 03/25/14 - 10:07 am
Seretide
Rituxan
Remicade
MabThera
Lantus
Humira
Herceptin
Enbrel
Crestor
Avastin
Advair
Abilify
Johnson & Johnson's Real Answer To Imminent Decline In Sales Of Top-Selling Drug
Seeking Alpha
Mon, 12/2/13 - 09:45 am
JNJ
Remicade
Olysio
hepatitis C
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
The 3 Best-Selling Drugs in the World
Motley Fool
Mon, 10/21/13 - 08:24 am
AbbVie
Humira
Remicade
JNJ
GSK
Advair
Johnson & Johnson Continues To Ride The Success Of Its Immunology And Oncology Drugs
Seeking Alpha
Fri, 10/18/13 - 10:07 am
JNJ
Remicade
Simponi
Stelara
Invokana
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
rheumatoid arthritis
Humira
AbbVie
Enbrel
Amgen
Remicade
Janssen
Celebrex
Pfizer
Bristol-Myers Squibb
Orencia
Cimza
UCB
Simponi
JNJ
Arthrotec
Vimovo
AstraZeneca
Kineret
Will This Biotech Approval Start a $100 Billion Trend?
Motley Fool
Fri, 09/13/13 - 08:34 am
drug approvals
Hospira
Remicade
biosimilars
Hospira all set to launch Remicade biosimilar in Europe
Pharma Times, UK
Thu, 09/12/13 - 10:16 am
Hospira
biosimilars
Remicade
Europe
JNJ
Merck
EU approves biosimilar of J&J and Merck's Remicade, WSJ says
Yahoo/Fly on the Wall
Wed, 09/11/13 - 08:48 am
Europe
biosimilars
JNJ
Merck
Remicade
rheumatoid arthritis
Low-profile Epirus lays claim to a PhIII success for Remicade biosimilar
Fierce Biotech
Thu, 08/29/13 - 11:16 am
Epirus
biosimilars
Remicade
BOW-015
rheumatoid arthritis
Is This Pharmaceutical Giant About To Lose Its Cornerstone Drug?
Motley Fool
Wed, 07/3/13 - 11:50 am
Celltrion
Hospira
Remicade
JNJ
Biosimilar versions of Remicade given EU green light
Reuters
Fri, 06/28/13 - 10:15 am
Remicade
biosimilars
Europe
Celltrion
Remsima
Hospira
Inflectra
rheumatoid arthritis
Celgene: Apremilast For Psoriatic Arthritis Offers Upside
Seeking Alpha
Tue, 05/14/13 - 05:22 pm
apremilast
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Remicade
Enbrel
Humira
Is Johnson & Johnson Heading Off The Patent Cliff?
Seeking Alpha
Mon, 05/13/13 - 09:12 am
JNJ
patent cliff
Novartis
Pfizer
Aciphex
Procrit
Velcade
Remicade
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Thu, 04/4/13 - 01:52 pm
investors
psoriasis
Amgen
Eli Lilly
Pfizer
Novartis
Celgene
Humira
AbbVie
Stelara
Remicade
Enbrel
apremilast
brodalumab
Xeljanz
Can JAK Inhibitors Challenge Biologics?
Motley Fool
Wed, 02/20/13 - 05:15 pm
JAK inhibitors
Remicade
JNJ
Enbrel
Stelara
Amgen
Humira
AbbVie
Merck's Weakest Blockbuster?
Motley Fool
Tue, 02/19/13 - 09:41 am
Merck
Remicade
rheumatoid arthritis
AbbVie
Humira
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »